AstroNova's Q2 Plunge: Revenue Drops, Net Loss Widens to $1.2M

Ticker: ALOT · Form: 10-Q · Filed: Sep 9, 2025 · CIK: 8146

Astronova, INC. 10-Q Filing Summary
FieldDetail
CompanyAstronova, INC. (ALOT)
Form Type10-Q
Filed DateSep 9, 2025
Risk Levelhigh
Pages15
Reading Time18 min
Key Dollar Amounts$0.05
Sentimentbearish

Sentiment: bearish

Topics: Earnings, Net Loss, Revenue Decline, Cash Flow, Product ID Segment, Aerospace Segment, MTEX Acquisition

TL;DR

**AstroNova's Q2 is a red flag; widening losses and revenue dip mean this stock is a sell until they prove they can integrate MTEX and turn a profit.**

AI Summary

AstroNova, Inc. reported a significant decline in financial performance for the three and six months ended July 31, 2025. Revenue decreased by 11% to $36.102 million for the three months ended July 31, 2025, compared to $40.539 million in the prior year period. The company posted a net loss of $1.243 million for the three months, a substantial increase from the $0.311 million net loss in the same period last year. For the six months ended July 31, 2025, revenue slightly increased to $73.810 million from $73.500 million, but the net loss widened to $1.619 million from a net income of $0.869 million in the prior year. Operating income swung to a loss of $0.708 million for the three months, down from a $1.061 million income. Key business changes include the renaming of the Test & Measurement segment to 'Aerospace' and the full integration of MTEX New Solution, S.A. into the Product ID segment. Risks include increased operating expenses, with General and Administrative expenses rising to $10.018 million for the six months from $8.488 million, and a decrease in cash and cash equivalents by $1.195 million to $3.855 million. The strategic outlook involves leveraging the MTEX acquisition to expand product offerings in industrial and commercial printing.

Why It Matters

AstroNova's widening net loss and declining revenue in the Product ID segment signal potential headwinds for investors, especially given the competitive landscape in digital printing. The integration of MTEX, while strategic, has yet to translate into improved profitability, raising questions about execution and market absorption. Employees might face pressure if cost-cutting measures become necessary to stem losses. For customers, the expanded product offerings from the MTEX acquisition could provide more diverse solutions, but the company's financial health could impact long-term support and innovation. The broader market will watch if AstroNova can stabilize its core business and leverage its acquisitions to regain momentum against larger, more diversified competitors.

Risk Assessment

Risk Level: high — The company reported a net loss of $1.243 million for the three months ended July 31, 2025, a significant increase from the $0.311 million net loss in the prior year. Cash and cash equivalents decreased by $1.195 million to $3.855 million, indicating a deteriorating liquidity position. Furthermore, operating income swung from a gain of $1.061 million to a loss of $0.708 million, demonstrating operational challenges.

Analyst Insight

Investors should consider reducing their exposure to ALOT given the significant decline in profitability and cash flow. Monitor future filings closely for signs of successful MTEX integration and a return to positive operating income, as the current trend suggests increasing financial strain.

Financial Highlights

revenue
$36.102M
net Income
($1.243M)
cash Position
$3.855M
revenue Growth
-11%

Revenue Breakdown

SegmentRevenueGrowth
Product ID
Aerospace

Key Numbers

Key Players & Entities

FAQ

What were AstroNova's key financial results for the quarter ended July 31, 2025?

AstroNova, Inc. reported revenue of $36.102 million for the three months ended July 31, 2025, an 11% decrease from $40.539 million in the prior year. The company posted a net loss of $1.243 million, significantly wider than the $0.311 million net loss in the same period last year.

How did AstroNova's net income change for the six months ended July 31, 2025?

For the six months ended July 31, 2025, AstroNova, Inc. reported a net loss of $1.619 million. This is a substantial decline from the net income of $0.869 million reported for the six months ended August 3, 2024.

What is the current cash position of AstroNova, Inc.?

As of July 31, 2025, AstroNova, Inc. had cash and cash equivalents of $3.855 million. This represents a decrease of $1.195 million from the beginning of the period.

What strategic changes did AstroNova make to its business segments?

Effective February 1, 2025, AstroNova, Inc. changed the name of its Test & Measurement segment to 'Aerospace' to better reflect its end markets. Additionally, MTEX New Solution, S.A., acquired on May 4, 2024, has been fully integrated into the Product ID segment.

What are the primary revenue drivers for AstroNova's Product ID segment?

The Product ID segment's revenue is approximately 80% from recurring supplies, parts, and service, including labels, tags, ink, and toner. Hardware sales, such as tabletop printers and flexible packaging printers, account for approximately 20% of the segment's revenue.

Who are the main customers for AstroNova's Aerospace segment?

Customers for AstroNova's Aerospace segment include defense industry prime contractors, aircraft OEMs, and commercial airlines for flight deck printers and networking systems. Data acquisition systems are sold to entities like NASA and defense industry prime contractors for high-precision applications.

What are the key risks highlighted in AstroNova's recent 10-Q filing?

Key risks include a significant increase in net loss, a decline in cash and cash equivalents, and a swing to an operating loss. General and Administrative expenses also rose to $10.018 million for the six months ended July 31, 2025, from $8.488 million in the prior year.

How has AstroNova's operating income changed year-over-year?

For the three months ended July 31, 2025, AstroNova's operating income swung to a loss of $0.708 million, a significant decrease from an operating income of $1.061 million in the three months ended August 3, 2024.

What is the impact of the MTEX acquisition on AstroNova's Product ID segment?

The MTEX acquisition, closed on May 6, 2024, expanded AstroNova's Product ID segment's product offerings to include mid-to-high volume direct-to-package printers, flexible packaging printers, and label printers, primarily targeting industrial and commercial printing segments.

What new accounting pronouncements is AstroNova evaluating?

AstroNova is evaluating ASU 2024-03, 'Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures,' which enhances expense disclosures, and ASU 2023-09, 'Income Taxes (Topic 740): Improvements to Income Tax Disclosures,' which modifies income tax disclosure requirements.

Risk Factors

Industry Context

AstroNova operates in the industrial and commercial printing and data acquisition/analysis markets. The company is seeking to leverage its recent acquisition of MTEX New Solution, S.A. to enhance its product offerings in the printing sector. The broader industry may be experiencing shifts towards digital solutions and increased demand for specialized data analytics.

Regulatory Implications

As a publicly traded company, AstroNova is subject to SEC regulations and reporting requirements. The financial results presented in the 10-Q are subject to audit and review, and any misstatements could lead to regulatory scrutiny or penalties.

What Investors Should Do

  1. Monitor expense management and cost control measures.
  2. Evaluate the integration and performance of MTEX New Solution, S.A.
  3. Assess the sustainability of the current cash position.
  4. Analyze segment performance beyond the provided percentages.

Key Dates

Glossary

Condensed Consolidated Statements of Income (Loss)
A financial statement that summarizes a company's revenues, expenses, and profits (or losses) over a specific period. (Provides the key figures for net income/loss and operating income/loss for the reported periods.)
Condensed Consolidated Balance Sheets
A financial statement that shows a company's assets, liabilities, and shareholders' equity at a specific point in time. (Shows the company's financial position, including cash and cash equivalents, as of July 31, 2025.)
Recurring Revenue
Revenue that a company can expect to receive repeatedly over time, often through subscriptions, service contracts, or repeat purchases. (Highlights the stable revenue stream within the Product ID segment, contributing 80% of its revenue.)

Year-Over-Year Comparison

Compared to the prior year period, AstroNova has experienced a significant downturn in its quarterly financial performance. Revenue for the three months ended July 31, 2025, fell by 11% to $36.102 million, and the company swung to a net loss of $1.243 million from a smaller loss of $0.311 million. While six-month revenue saw a slight increase, the net loss widened considerably from a profit of $0.869 million to a loss of $1.619 million. Key risks have emerged or intensified, including rising General and Administrative expenses and a reduced cash position.

Filing Stats: 4,426 words · 18 min read · ~15 pages · Grade level 17.4 · Accepted 2025-09-09 14:00:57

Key Financial Figures

Filing Documents

Financial Statements

Financial Statements Unaudited Condensed Consolidated Balance Sheets – July 31, 2025 and January 31, 2025 1 Unaudited Condensed Consolidated Statements of Income (Loss) – Three and Six Months Ended July 31 , 2025 and August 3, 2024 2 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) – Three and Six Months Ended July 31 , 2025 and August 3 , 2024 3 Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity – Three and Six Months Ended July 31 , 2025 and August 3 , 2024 4 Unaudited Condensed Consolidated Statements of Cash Flows – Six Months Ended July 31 , 2025 and August 3 , 2024 5 Notes to the Condensed Consolidated Financial Statements (unaudited) 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 37 Item 4.

Controls and Procedures

Controls and Procedures 37 Part II. Other Information 37 Item 1.

Legal Proceedings

Legal Proceedings 37 Item 1A.

Risk Factors

Risk Factors 38 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38 Item 6. Exhibits 40

Signatures

Signatures 41 Pa rt I. FINANCIAL INFORMATION It em 1. Financial Statements ASTRONOVA, INC. CONDENSED CONSOL IDATED BALANCE SHEETS (In Thousands, Except Share Data) July 31, 2025 January 31, 2025 (Unaudited) ASSETS CURRENT ASSETS Cash and Cash Equivalents $ 3,855 $ 5,050 Accounts Receivable, net 18,535 21,218 Inventories, net 48,393 47,894 Prepaid Expenses and Other Current Assets 4,447 3,855 Total Current Assets 75,230 78,017 Property, Plant and Equipment, net 17,018 17,639 Identifiable Intangibles, net 22,729 23,519 Goodwill 15,279 14,515 Deferred Tax Assets, net 8,535 8,431 Right of Use Asset 2,689 1,781 Other Assets 1,669 1,693 TOTAL ASSETS $ 143,149 $ 145,595 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts Payable $ 6,908 $ 7,928 Accrued Compensation 4,324 3,745 Other Accrued Expenses 4,520 4,461 Revolving Line of Credit 19,079 20,929 Current Portion of Long-Term Debt 5,559 6,110 Short-Term Debt 253 581 Current Liability—Royalty Obligation 1,218 1,358 Current Liability—Excess Royalty Payment Due 556 691 Deferred Revenue 1,459 543 Total Current Liabilities 43,876 46,346 NON-CURRENT LIABILITIES Long-Term Debt, net of current portion 18,566 19,044 Lease Liabilities, net of current portion 2,235 1,535 Grant Deferred Revenue 1,101 1,090 Royalty Obligation, net of current portion 858 1,106 Income Taxes Payable 684 684 Deferred Tax Liabilities — 40 Other Long-Term Liability 43 — TOTAL LIABILITIES 67,363 69,845 SHAREHOLDERS' EQUITY Preferred Stock, $ 10 Par Value, Authorized 100,000 shares, None Issued — — Common Stock, $ 0.05 Par Value, Authorized 13,000,000 shares; Issued 11,035,656 and 10,936,220 shares at July 31, 2025 and January 31, 2025, respectively 552 547 Additional Paid-in Capital 65,023 64,215 Retained

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing